Inhibitors of V-ATPase Proton Transport Reveal Uncoupling Functions of Tether Linking Cytosolic and Membrane Domains of V0 Subunit a (Vph1p)
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Vacuolar ATPase (V-ATPase) proton pumps maintain pH homeostasis.Results: We discovered new V-ATPase inhibitors that uncouple the proton transport and ATPase activity of the pump.Conclusion: Residues at the tether connecting V 0 subunit a to the membrane give uncoupling potential to V-ATPases.Significance: The tether may offer new mechanisms to regulate V-ATPase and cellular pH in vivo by uncoupling the pump.Vacuolar ATPases (V-ATPases) are important for many cellular processes, as they regulate pH by pumping cytosolic protons into intracellular organelles.The cytoplasm is acidified when V-ATPase is inhibited; thus we conducted a highthroughput screen of a chemical library to search for compounds that acidify the yeast cytosol in vivo using pHluorin-based flow cytometry.Two inhibitors, alexidine dihydrochloride (EC 50 ؍ 39 M) and thonzonium bromide (EC 50 ؍ 69 M), prevented ATP-dependent proton transport in purified vacuolar membranes.They acidified the yeast cytosol and caused pH-sensitive growth defects typical of V-ATPase mutants (vma phenotype).At concentrations greater than 10 M the inhibitors were cytotoxic, even at the permissive pH (pH 5.0).Membrane fractions treated with alexidine dihydrochloride and thonzonium bromide fully retained concanamycin A-sensitive ATPase activity despite the fact that proton translocation was inhibited by 80 -90%, indicating that V-ATPases were uncoupled.Mutant V-ATPase membranes lacking residues 362-407 of the tether of Vph1p subunit a of V 0 were resistant to thonzonium bromide but not to alexidine dihydrochloride, suggesting that this conserved sequence confers uncoupling potential to V 1 V 0 complexes and that alexidine dihydrochloride uncouples the enzyme by a different mechanism.The inhibitors also uncoupled the Candida albicans enzyme and prevented cell growth, showing further specificity for V-ATPases.Thus, a new class of V-ATPase inhibitors (uncouplers), which are not simply ionophores, provided new insights into the enzyme mechanism and original evidence supporting the hypothesis that V-ATPases may not be optimally coupled in vivo.The consequences of uncoupling V-ATPases in vivo as potential drug targets are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The vacuolar (H+)-ATPases — nature's most versatile proton pumps
Nishi, T., & Forgac, M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm729 · Cited by 1,197
An insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432
Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast
Martínez-Muñoz, G. A., & Kane, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710470200 · Cited by 257 · cited 5×
“Yeast cytosolic pH is maintained through a concerted movement of protons out of the cytosol by the V-ATPase and Pma1p pumps, the major electrogenic pumps at the vacuolar and plasma membranes, respectively (13, 29).”
BackgroundMethodResultInfluentialRequirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
Zhang, Y.-Q., Gamarra, S., Garcia-Effron, G., Park, S., Perlin, D. S., & Rao, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000939 · Cited by 206 · cited 1×
“Further studies will specifically assess the anti-virulence mechanisms behind these drugs and the efficacy of combining these uncouplers with other antifungal therapeutics such as azoles, which also alter V-ATPase activity (57).”
BackgroundThe mechanism of rotating proton pumping ATPases
Nakanishi-Matsui, M., Sekiya, M., Nakamoto, R. K., & Futai, M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.014 · Cited by 120 · cited 1×
“V0 is membrane-bound and forms the path for proton transport, which involves subunit a and a proteolipid ring structure (3, 7).”
Background
Cited by
Siles, S. A., Srinivasan, A., Pierce, C. G., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00680-13 · Cited by 120
“Alexidine dihydrochloride is an antibacterial agent used effectively as a biocide against a wide range of Gram-positive and Gram-negative bacteria and also against the yeast Saccharomyces cerevisiae (28, 29).”
BackgroundFeng, J., Weitner, M., Shi, W., Zhang, S., Sullivan, D., & Zhang, Y. (2015) · Antibiotics · doi:10.3390/antibiotics4030397 · Cited by 43
“albicans, thonzonium bromide was also shown to inhibit ATPases in isolated vacuoles and cause general cellular toxicity [33,34].”
BackgroundChan, C.-Y., Dominguez, D., & Parra, K. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.717488 · Cited by 23
“Proton transport was measured by monitoring 9-amino-6-chloro-2-methoxyacridin quenching after addition of MgATP (48).”
BackgroundMethodSelf-citationAttenuation of Candida albicans virulence with focus on disruption of its vacuole functions
Olsen, I. (2014) · Journal of Oral Microbiology · doi:10.3402/jom.v6.23898 · Cited by 22
“(35) used the pHluorin screening method on the Prestwick Chemical Library containing 1,120 offpatent drugs and identified alexidine dihydrochloride and thonzonium bromide as new and specific ATPase inhibitors.”
Method
Metadata
- Authors
- Chan, C.-Y., Prudom, C., Raines, S. M., Charkhzarrin, S., Melman, S. D., De Haro, L. P., Allen, C., Lee, S. A., Sklar, L. A., & Parra, K. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 287
- Issue
- 13
- Pages
- 10236-10250
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984181608
- Cited by
- 56
- References
- 5
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.